SLU-PP-332 (100mg/capsule), 60 Capsules
$196.95
SLU-PP-332 is a selective pan-estrogen receptor-related receptor (ERR) agonist with demonstrated activity across ERRα, ERRβ, and ERRγ subtypes. The compound exhibits properties related to enhanced mitochondrial biogenesis and oxidative phosphorylation in cellular models. Each unit contains 100mg of the active… CAS: 303760-60-3 | Formula: C18H14N2O2 | Content: 6,000 mg (100 mg per capsule) | Research use only | Third-party lab tested.
Buy SLU-PP-332 (100mg/capsule), 60 Capsules – Swiss Chems USA
SLU-PP-332 (100mg/capsule), 60 Capsules — Research Overview
SLU-PP-332 is a selective pan-estrogen receptor-related receptor (ERR) agonist with demonstrated activity across ERRα, ERRβ, and ERRγ subtypes. The compound exhibits properties related to enhanced mitochondrial biogenesis and oxidative phosphorylation in cellular models. Each unit contains 100mg of the active molecule, supplied in 60-count containers for research applications. The compound is intended exclusively for analytical and laboratory research purposes.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
Intended use: This material is supplied for laboratory and in-vitro research only. It is not a drug, food, or cosmetic and is not intended for human or animal consumption.
SLU-PP-332 (100mg/capsule), 60 Capsules Chemical Properties
| Property | Specification |
|---|---|
| Chemical Formula | C18H14N2O2 |
| Synonyms | 4-Hydroxy-N’-(naphthalen-2-ylmethylene)benzohydrazide |
| Molar Mass | 290.32 g/mol |
| CAS Number | 303760-60-3 |
| PubChem CID | 5338394 |
| Total Compound Content | 6,000 mg (100 mg per capsule) |
| Shelf Life | 36 months |
SLU-PP-332 (100mg/capsule), 60 Capsules Research Applications
SLU-PP-332 is a synthetic pan-agonist of the estrogen-related receptor (ERR) subfamily, exhibiting activity across ERRα, ERRβ, and ERRγ receptor subtypes. These orphan nuclear receptors function as constitutively active transcription factors that regulate gene expression programs through interactions with coactivator proteins and transcriptional regulatory complexes. SLU-PP-332 has been characterized as a highly selective and potent pan-ERR agonist, making it a valuable research tool for investigating ERR receptor pharmacology, receptor-coactivator interactions, and nuclear receptor-mediated signaling pathways.
SLU-PP-332 (100mg/capsule), 60 Capsules Lab Results & Certificates of Analysis
Third-party analytical reports associated with this research compound:
SLU-PP-332 (100mg/capsule), 60 Capsules Frequently Asked Questions
What are estrogen-related receptors (ERRs) and why is SLU-PP-332 significant as a pan-agonist?
ERRα, ERRβ, and ERRγ are orphan nuclear receptors that function as constitutively active transcription factors within the nuclear receptor superfamily. These receptors regulate gene expression through interactions with coactivator proteins and transcriptional regulatory complexes. SLU-PP-332 is notable for exhibiting activity across all three ERR subtypes, making it a valuable research tool for investigating pan-ERR receptor pharmacology, receptor-coactivator interactions, and the coordinated regulation of ERR-dependent transcriptional signaling networks.
What makes SLU-PP-332 useful for ERR receptor research?
SLU-PP-332 possesses a highly selective pan-ERR activity profile, enabling experimental investigation of ERRα-, ERRβ-, and ERRγ-mediated signaling within a single molecular framework. This characteristic allows researchers to examine receptor activation mechanisms, coactivator recruitment processes, transcriptional control systems, and downstream regulatory pathways associated with ERR signaling. Its well-characterized pharmacological profile has established it as an important tool for studies of orphan nuclear receptor biology.
How does SLU-PP-332 differ from other nuclear receptor agonists?
SLU-PP-332 selectively targets the estrogen-related receptor family, whereas many other nuclear receptor agonists act through distinct receptor systems with different signaling architectures and transcriptional regulatory mechanisms. This receptor specificity makes SLU-PP-332 useful for comparative investigations of nuclear receptor pharmacology, receptor-ligand interactions, coactivator biology, and the molecular processes governing receptor-mediated transcriptional regulation.
Research Use Disclaimer
All product information is provided for educational and laboratory research reference only. Any form of introduction into humans or animals is prohibited. Handle only in licensed research settings in accordance with applicable laws and institutional protocols.
Reviews
There are no reviews yet.